• Merimepodib (VX-497): Protocols and Troubleshooting for IMPD

  2026-08-05

  Merimepodib (VX-497) empowers researchers with precise, reversible inhibition of IMPDH, unlocking advanced experimental control in oncology, immunology, and virology. This guide distills current protocols, troubleshooting strategies, and novel insights from recent bench research, with actionable workflows for maximizing data reproducibility and specificity.

• Bedaquiline: Diarylquinoline Antibiotic in MDR-TB & Cancer R

  2026-08-05

  Bedaquiline redefines research in multi-drug resistant tuberculosis and cancer metabolism by uniquely inhibiting ATP synthase in both pathogens and cancer stem cells. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies that empower scientists to maximize the impact of Bedaquiline in advanced disease models.

• Sulforaphane (C4733): Reliable Cell Assay Solutions & Protoc

  2026-08-04

  This article provides an evidence-based, scenario-driven guide to using Sulforaphane (SKU C4733) in cell viability, proliferation, and cytotoxicity assays. Emphasizing reproducibility and mechanistic clarity, it walks biomedical researchers through protocol optimization, data interpretation, and product selection—highlighting Sulforaphane’s validated performance for oxidative stress response and cancer chemoprevention research.

• Sumatriptan Succinate: Optimizing 5-HT1 Receptor Agonist Wor

  2026-08-04

  Sumatriptan Succinate empowers migraine and inflammation research with unrivaled selectivity for 5-HT1B/1D receptors, robust DMSO solubility, and proven translational impacts. This guide delivers actionable protocols, troubleshooting strategies, and insights from recent clinical and bench advances to maximize your experimental success.

• CD147+ sEVs Drive Angiogenesis in HCC via PI3K/Akt Pathway

  2026-08-03

  Huang et al. identify small extracellular vesicles (sEVs) bearing CD147 as both a diagnostic marker and a functional driver of angiogenesis in hepatocellular carcinoma (HCC), acting through PI3K/Akt pathway activation. These findings highlight CD147+ sEVs as a novel target for noninvasive diagnosis and anti-angiogenic therapy in HCC.

• Omeprazole (A2845): Technical Guidance for Gastric Acid Rese

  2026-08-03

  Omeprazole (A2845) is a high-purity H+,K+-ATPase inhibitor designed for controlled scientific studies of gastric acid secretion and antiulcer mechanisms. It should be used exclusively in preclinical, in vitro, or ex vivo workflows and is not intended for diagnostic or clinical applications. Adherence to specialized protocols is essential for reliable results and compound stability.

• X-press Tag Peptide: Optimizing N-terminal Leader Purificati

  2026-08-02

  X-press Tag Peptide empowers researchers with a modular N-terminal leader for streamlined affinity purification, precise detection, and efficient enterokinase cleavage. This article details workflow enhancements and troubleshooting strategies, bridging recent RHEB neddylation discoveries to practical assay design.

• ML216: Selective BLM Helicase Inhibitor for DNA Repair Resea

  2026-08-01

  ML216 is a potent BLM helicase inhibitor with submicromolar activity, offering unique selectivity and mechanistic insights into homologous recombination pathway inhibition. Its validated use in DNA repair and synthetic lethality models positions it as a precision tool for cancer research.

• E-64d: Membrane-Permeable Calpain Inhibitor for Cell Death R

  2026-07-31

  E-64d is a membrane-permeable, irreversible cysteine protease inhibitor optimized for the inhibition of calpain and cathepsin activities. With robust cell entry and submicromolar IC50, E-64d enables precise dissection of apoptosis and neuroprotection pathways in vitro and in vivo. APExBIO’s A1903 formulation provides reproducible results for research on regulated cell death, platelet activation, and seizure-induced neuroprotection.

• Haloprogin: Mechanistic Insights and Next-Gen Antifungal Res

  2026-07-31

  Explore Haloprogin’s unique molecular action, advanced assay integration, and evidence-based advantages for antifungal and Gram-positive bacterial research. This article reveals protocol-critical findings and practical innovations missing from existing overviews.

• Nystatin (Fungicidin): Innovations in Antifungal Research Mo

  2026-07-30

  Explore how Nystatin (Fungicidin) advances antifungal research by targeting Candida species and mycoplasma. Discover unique insights into nanoparticle delivery, resistance, and translational model optimization in this in-depth scientific analysis.

• Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis

  2026-07-30

  This study develops a prognostic model for hepatocellular carcinoma (HCC) based on ferroptosis-related genes and identifies atorvastatin as a candidate inducer of ferroptosis in HCC cells. The work provides new opportunities for prognosis prediction and targeted treatment in HCC, with direct experimental validation of atorvastatin’s antitumor effects.

• Short-Scale Break-Induced Replication in Mouse Oocytes: Insi

  2026-07-29

  This study reveals that DNA double-strand breaks (DSBs) trigger a unique short-scale break-induced replication (ssBIR) in fully grown mouse oocytes, amplifying DNA damage under specific regulatory controls. The findings clarify the mechanisms and modulation of ssBIR, with implications for genome stability and experimental DNA repair research.

• Concanamycin A in Cancer Biology: Beyond Endosomal Acidifica

  2026-07-29

  Explore the advanced roles of Concanamycin A, a potent V-type H+-ATPase inhibitor, in cancer biology research. This in-depth article goes beyond standard protocols to reveal mechanistic insights, assay design strategies, and new practical guidance for utilizing Concanamycin A in the study of apoptosis and tumor invasiveness.

• Brefeldin A: Optimizing Vesicle Transport and ER Stress Assa

  2026-07-28

  Brefeldin A (BFA) is a gold-standard tool for dissecting ER-to-Golgi trafficking and apoptosis in cancer and vascular models. This guide reveals protocol-anchored workflows, troubleshooting strategies, and the unique translational value of BFA—anchored by APExBIO’s high-purity formulation.

453 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page